- Sourcews Report
- File
- HTML
- Size
- 26 Ko
- URL response
- 100%
- Source quality
- 100%
- Sourcews Explorer
Royal Dutch pharmaceutical society signs outsourcing agreement with BT
12.06.08 - 20:57 ... source : BT Group
... 5-year, €2.6 million outsourcing contract covers outsourcing of mission critical IT-infrastructure BT has signed a contract with the Royal Dutch Pharmaceutical Society (KNMP), an association for all pharmacists in The Netherlands. More than 90 percent of all Dutch pharmacists are member of the KNMP. Under the terms of the 5-year agreement, KNMP outsources its entire mission critical ICT-infrastructure to BT. Niek den Toom, Manager ICT & Business Innovation of KNMP: "Considering our long-standing relationship with BT and their bre ...» Next (HTML)
Similar news
95% | 07.05.08 - 22:01 ... source : Enel
... sell EBRD an interest of about 4.1% of OGK-5 for about 175 million euros. Rome/Moscow, 7 May 2008 Enel Investment Holding B.V. (EIH, a wholly-owned Dutch subsidiary of Enel S.p.A.) and the European Bank for Reconstruction and Development (EBRD) ...
91% | 16.04.08 - 11:48 ... source : Pearson Vue
... UK has signed a contract with Pearson VUE to deliver new Specialty Knowledge Based Assessments (KBAs) in 13 subjects with a phased rollout commencing immediately. These are: Acute Medicine; Cardiology; Clinical Pharmacology and Therapeutics; Dermatology; Endocrinology and Diabetes; Gastroenterology; Geriatric ...
90% | 12.05.08 - 20:30 ... source : Volcano Corporation
... (Nasdaq: VOLC), leading manufacturer of intravascular ultrasound (IVUS), announced today that it has entered into a non-exclusive, resale agreement covering North America with Royal Philips Electronics. Under this agreement, Philips will resell Volcano-branded s5i IVUS systems and accessories alongside of ...
88% | 20.05.08 - 08:05 ... source : Crucell
... Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STARŪ research license agreement with Bioceros. The license agreement with the Netherlands based company Bioceros covers the production of monoclonal antibodies. Financial details of the agreement were not ...
87% | 29.04.08 - 09:02 ... source : Crucell
... company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STARŪ research license agreement with Toyobo Gene Analysis Co. LTD. Under the agreement, Toyobo Gene Analysis will evaluate Crucell's STARŪ technology for generating cell lines for the ...
